T1	Participants 97 203	High-dose combinations of fosamprenavir (FPV) and ritonavir (RTV) were evaluated in healthy adult subjects
T2	Participants 607 689	Forty-two healthy adult subjects were enrolled, and 39 subjects completed period 1
